Want to see GB:IKA full AI Analyst Report?
IKA Stock Chart & Stats
27.00 p
-0.69 p(-2.38%)
At close: 4:00 PM EDT
27.00 p
-0.69 p(-2.38%)
Day’s Range― - ―
52-Week Range22.13 p - 51.00 p
Previous CloseN/A
Volume24.50K
Average Volume (3M)242.89K
Market Cap
£46.24M
Enterprise Value55.40 p
Total Cash (Recent Filing)£5.35M
Total Debt (Recent Filing)£1.08M
Price to Earnings (P/E)―
Beta0.58
Next Earnings
Jan 28, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding198,889,310
10 Day Avg. Volume297,607
30 Day Avg. Volume242,888
Financial Highlights & Ratios
PEG Ratio-0.98
Price to Book (P/B)4.11
Price to Sales (P/S)526.11
P/FCF Ratio-11.07
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.04
Revenue Forecast (FY)£2.00M
Bulls Say, Bears Say
Bulls Say
Strong Intellectual Property PortfolioAn extensive granted-patent portfolio can protect Ilika’s technology, strengthen licensing discussions, and differentiate its cells as commercialization develops. This intellectual-property base may support durable bargaining power with manufacturers and customers over the next several quarters.
Stereax Commercialization And Manufacturing PartnershipStereax customer deliveries represent an initial shift from development activity toward commercial revenue. Cirtec’s wafer scale-up and U.S. manufacturing capability provide a credible route to broader production, while the agreement creates potential for recurring licensing and royalty-related income.
Pilot-line Capability And Process ValidationDemonstrated compatibility with larger production equipment may reduce integration barriers for prospective licensees and partners. Although current capacity is limited, an operating pilot line gives Ilika a platform to validate cell designs, support customer trials, and advance toward scalable commercialization.
Bears Say
Persistent Unprofitable Operating ModelPersistent negative margins show that Ilika has not yet established a scalable, profitable revenue model. Even with stronger top-line activity, continuing losses can consume resources, limit reinvestment flexibility, and make successful commercialization necessary before financial performance can improve durably.
Ongoing Cash Burn And Funding DependenceSustained operating cash outflows mean Ilika must continue funding research, validation, and commercialization before internally generated cash can support the business. Dependence on grants, partnerships, or additional capital raises creates execution and potential dilution pressure over the medium term.
Limited Scale And Delayed Automotive CommercializationCurrent pilot capacity supports prototypes and smaller applications but is far below automotive-scale requirements. Lengthy cycle-life validation and staged licensing can delay major revenue realization, leaving the company exposed to extended development timelines before large commercial orders emerge.
Ilika plc News
IKA FAQ
What was Ilika PLC’s price range in the past 12 months?
Ilika PLC lowest share price was 22.13 p and its highest was 51.00 p in the past 12 months.
What is Ilika PLC’s market cap?
Ilika PLC’s market cap is £46.24M.
When is Ilika PLC’s upcoming earnings report date?
Ilika PLC’s upcoming earnings report date is Jan 28, 2027 which is in 128 days.
How were Ilika PLC’s earnings last quarter?
Ilika PLC released its earnings results on Jul 29, 2026. The company reported -0.02 p earnings per share for the quarter.
Is Ilika PLC overvalued?
According to Wall Street analysts Ilika PLC’s price is currently Overvalued.
Does Ilika PLC pay dividends?
Ilika PLC does not currently pay dividends.
What is Ilika PLC’s EPS estimate?
Ilika PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ilika PLC have?
Ilika PLC has 198,889,310 shares outstanding.
What happened to Ilika PLC’s price movement after its last earnings report?
Ilika PLC reported an EPS of -0.02 p in its last earnings report. Following the earnings report the stock price went down -8.772%.
Which hedge fund is a major shareholder of Ilika PLC?
Currently, no hedge funds are holding shares in GB:IKA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ilika plc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
GB:IKA Sentiment 100%
Sector Average 61%
Sector Average 61%
Insider Transactions
Bought Shares
Worth £20.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-35.41%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-13.78%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Ilika PLC
Ilika plc, an enterprise established in 2004 with its headquarters in Romsey, United Kingdom, focuses on the conception, refinement, and commercial production of solid-state battery technology. These advanced power cells are distributed globally under their Stereax brand, primarily serving markets in the UK, Asia, mainland Europe, and North America. The company's battery solutions find application across numerous sectors, such as industrial Internet of Things, medical apparatus, various transportation systems including electric vehicles, and portable consumer electronics, as well as supporting smart city initiatives.